Teva Recalls Qnasl Nasal Aerosol Due to Potential Clogged Stem Valves
Teva Pharmaceuticals USA is recalling Qnasl Nasal Aerosol units because some may have clogged stem valves, potentially affecting delivery.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences, fitting the 'Low' severity criteria for documentation or minor defects.
Plain-English summary
Teva Pharmaceuticals USA is recalling specific lots of Qnasl (beclomethasone dipropionate) Nasal Aerosol, 80 mcg per spray. The recall involves 379,463 inhalers distributed nationwide and in Puerto Rico. The affected lots are 120004, 120095, 120131, 120131 2, 120271, and 120351, with expiration dates ranging from January 2014 to August 2014.
The recall was initiated due to a defective delivery system. There is a potential for some units in these lots to have clogged stem valves, which may prevent the medication from being delivered properly. The FDA has classified this as a Class III recall, indicating that the defect is not likely to cause adverse health consequences.
Consumers with these specific lots of Qnasl should stop using the product and contact their healthcare provider or pharmacist for a replacement or further instructions. The product is prescription-only, so patients should consult their prescriber regarding alternative treatments if necessary.
The recalled product
- Product
- Qnasl (beclomethasone dipropionate) Nasal Aerosol, 80 mcg per spray, 120 metered sprays, 8.7 g inhaler, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044; By: 3M Delivery Systems, Northridge, CA 91324, NDC 59310-210-12, UPC 3 59310 21012 9.
- Manufacturer
- Teva Pharmaceuticals USA
- Category
- Drug — Nasal Aerosol
- Affected units
- 379,463
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot #: 120004
- Exp 01/14
- 120095
- 120131
- 120131 2
- Exp 03/14
- 120271
- Exp 07/14
- 120351
- Exp 08/14
Distribution
Related recalls
Same manufacturer · Teva Pharmaceuticals USA
See all →- ModerateDoxylamine Succinate and Pyridoxine Hydrochloride Tablets Recalled for Failed Dissolution
FDA (Drugs) · 2022-02-09
- LowPrescription Drug Recall: Mimvey Mislabeling by Teva Pharmaceuticals
FDA (Drugs) · 2022-02-09
- ModerateTretinoin Capsules 10 mg Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2022-02-09
- LowMimvey Estradiol/Norethindrone Prescription Drug Mislabeling Recall
FDA (Drugs) · 2022-02-09
- ModerateBrinzolamide Ophthalmic Suspension recalled for defective container caps
FDA (Drugs) · 2022-01-26
Same hazard · defective delivery system
See all →- ModerateCetrorelix injection kits recalled over missing or duplicated needles inside
FDA (Drugs) · 2026-02-18
- HighAIRSUPRA Albuterol and Budesonide Inhalation Aerosol Recalled for Defective Delivery System
FDA (Drugs) · 2025-05-28
- HighLorazepam Oral Syringes Recalled Due to Defective Delivery System Causing Leakage
FDA (Drugs) · 2025-03-12
- ModerateVarithena Administration Pack Recalled Due to Incorrect Syringe Connector Type
FDA (Drugs) · 2024-12-18
- HighDaytrana Methylphenidate Transdermal Patches Recalled for Defective Delivery System
FDA (Drugs) · 2023-03-29